A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

NCT03535727 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma
Pancreatic Neoplasms
Neoplasm, Glandular
Neoplasms
Neoplasms Pancreatic
Digestive System Neoplasm
Endocrine Gland Neoplasms
Digestive System Disease
Pancreatic Diseases
Endocrine System Diseases

Interventions

DRUG: Nab-paclitaxel
DRUG: Gemcitabine
DRUG: Capecitabine
DRUG: Cisplatin
DRUG: Irinotecan
DRUG: Nab-paclitaxel
DRUG: Gemcitabine
DRUG: Capecitabine
DRUG: Cisplatin
DRUG: Irinotecan

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins